Integral Health Asset Management as of June 30, 2025
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 71 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 14.7 | $161M | 1.6M | 100.64 | |
| Boston Scientific Corporation (BSX) | 5.4 | $59M | 550k | 107.41 | |
| Cytokinetics Com New Call Option (CYTK) | 4.5 | $50M | 1.5M | 33.04 | |
| Tenet Healthcare Corp Com New (THC) | 4.4 | $48M | 275k | 176.00 | |
| Encompass Health Corp (EHC) | 3.6 | $39M | 320k | 122.63 | |
| Mineralys Therapeutics (MLYS) | 3.3 | $37M | 2.7M | 13.53 | |
| Brightspring Health Svcs (BTSG) | 2.7 | $30M | 1.3M | 23.59 | |
| Vera Therapeutics Cl A (VERA) | 2.5 | $27M | 1.2M | 23.56 | |
| Quest Diagnostics Incorporated (DGX) | 2.5 | $27M | 150k | 179.63 | |
| Regeneron Pharmaceuticals (REGN) | 2.4 | $26M | 50k | 525.00 | |
| Novartis Sponsored Adr (NVS) | 2.2 | $24M | 200k | 121.01 | |
| Cardinal Health (CAH) | 2.2 | $24M | 140k | 168.00 | |
| Anthem (ELV) | 2.1 | $23M | 60k | 388.96 | |
| RadNet (RDNT) | 2.1 | $23M | 400k | 56.91 | |
| Fresenius Medical Care Sponsored Adr (FMS) | 2.0 | $21M | 750k | 28.57 | |
| Eli Lilly & Co. (LLY) | 1.8 | $20M | 25k | 779.53 | |
| Neurocrine Biosciences (NBIX) | 1.7 | $19M | 150k | 125.69 | |
| Uniqure Nv SHS (QURE) | 1.7 | $19M | 1.4M | 13.94 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $18M | 55k | 326.09 | |
| Dex (DXCM) | 1.6 | $18M | 200k | 87.29 | |
| Charles River Laboratories (CRL) | 1.6 | $17M | 115k | 151.73 | |
| Medtronic SHS (MDT) | 1.6 | $17M | 200k | 87.17 | |
| CVS Caremark Corporation (CVS) | 1.6 | $17M | 250k | 68.98 | |
| Pfizer (PFE) | 1.6 | $17M | 700k | 24.24 | |
| Edwards Lifesciences (EW) | 1.4 | $16M | 200k | 78.21 | |
| Ge Healthcare Technologies I Common Stock (GEHC) | 1.4 | $15M | 200k | 74.07 | |
| Astrazeneca Sponsored Adr (AZN) | 1.3 | $14M | 200k | 69.88 | |
| Edgewise Therapeutics (EWTX) | 1.2 | $13M | 1.0M | 13.11 | |
| Oric Pharmaceuticals (ORIC) | 1.2 | $13M | 1.3M | 10.15 | |
| Revolution Medicines (RVMD) | 1.1 | $12M | 325k | 36.79 | |
| 89bio (ETNB) | 0.9 | $10M | 1.1M | 9.82 | |
| Penumbra (PEN) | 0.9 | $10M | 40k | 256.63 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.9 | $9.4M | 200k | 47.20 | |
| Inspire Med Sys (INSP) | 0.8 | $9.1M | 70k | 129.77 | |
| Acadia Healthcare (ACHC) | 0.8 | $9.1M | 400k | 22.69 | |
| Beam Therapeutics (BEAM) | 0.8 | $8.5M | 500k | 17.01 | |
| Hologic (HOLX) | 0.7 | $8.1M | 125k | 65.16 | |
| Tarsus Pharmaceuticals (TARS) | 0.7 | $8.1M | 200k | 40.51 | |
| Rezolute Com New (RZLT) | 0.7 | $8.0M | 1.8M | 4.46 | |
| Rhythm Pharmaceuticals (RYTM) | 0.7 | $7.6M | 120k | 63.19 | |
| Baxter International (BAX) | 0.7 | $7.6M | 250k | 30.28 | |
| Abbvie (ABBV) | 0.7 | $7.4M | 40k | 185.62 | |
| McKesson Corporation (MCK) | 0.7 | $7.3M | 10k | 732.78 | |
| Roivant Sciences SHS (ROIV) | 0.6 | $6.8M | 600k | 11.27 | |
| Irhythm Technologies (IRTC) | 0.6 | $6.2M | 40k | 153.96 | |
| Agilent Technologies Inc C ommon (A) | 0.5 | $5.9M | 50k | 118.01 | |
| Regenxbio Inc equity us cm (RGNX) | 0.5 | $5.7M | 700k | 8.21 | |
| Verona Pharma Sponsored Ads (VRNA) | 0.5 | $5.7M | 60k | 94.58 | |
| Alignment Healthcare (ALHC) | 0.5 | $5.6M | 400k | 14.00 | |
| Atyr Pharma Com New (ATYR) | 0.5 | $5.3M | 1.1M | 5.07 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $5.3M | 100k | 53.14 | |
| Viking Therapeutics Call Option (VKTX) | 0.5 | $5.3M | 200k | 26.50 | |
| Waters Corporation (WAT) | 0.5 | $5.2M | 15k | 349.04 | |
| Glaukos (GKOS) | 0.5 | $5.2M | 50k | 103.29 | |
| Elanco Animal Health (ELAN) | 0.5 | $5.0M | 350k | 14.28 | |
| Cooper Cos (COO) | 0.5 | $5.0M | 70k | 71.16 | |
| Crispr Therapeutics Namen Akt (CRSP) | 0.4 | $4.9M | 100k | 48.64 | |
| Protara Therapeutics Com Stk (TARA) | 0.4 | $4.2M | 1.4M | 3.03 | |
| Biohaven (BHVN) | 0.4 | $4.2M | 300k | 14.11 | |
| Sana Biotechnology (SANA) | 0.4 | $4.1M | 1.5M | 2.73 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $3.6M | 100k | 36.36 | |
| Scholar Rock Hldg Corp (SRRK) | 0.3 | $3.5M | 100k | 35.42 | |
| Nurix Therapeutics (NRIX) | 0.3 | $3.5M | 310k | 11.39 | |
| Jasper Therapeutics Com New (JSPR) | 0.3 | $3.3M | 590k | 5.55 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $3.3M | 150k | 21.70 | |
| Alkermes SHS (ALKS) | 0.3 | $2.9M | 100k | 28.61 | |
| Terns Pharmaceuticals (TERN) | 0.2 | $2.6M | 700k | 3.73 | |
| Arcus Biosciences Incorporated (RCUS) | 0.2 | $2.4M | 300k | 8.14 | |
| Oscar Health Cl A (OSCR) | 0.2 | $2.1M | 100k | 21.44 | |
| Tenax Therapeutics Com New (TENX) | 0.1 | $962k | 167k | 5.76 | |
| Alto Neuroscience Com Shs (ANRO) | 0.1 | $880k | 400k | 2.20 |